New York, Sept. 18 -- New Delhi:Russia's sovereign wealth fund has agreed a deal to sell 100 million doses of its Covid-19 vaccine, Sputnik-V, to India. The media also reported that Indian pharmaceutical giant, Dr Reddy's Laboratories based in Hyderabad will be responsible for marketing and distributing the vaccine in the country.
Clinical trials of the Russian vaccine in India are expected to follow and to be held jointly with Dr Reddy's. Both the trials and supply deal depend on domestic regulatory approval.
Russia has billed Sputnik-V as the first vaccine against coronavirus to be registered in the world. Large-scale trials, known as Phase III, involving at least 40,000 people, were launched in Russia on Aug. 26.New reports to come out...